Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

BACKGROUND: There are no specific generally accepted therapies for the coronavirus disease 2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild respiratory tract illness to severe pneumonia, acute respiratory distress syndrome (ARDS), multisystem organ failure, and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Villar, Jesús, Añón, José M., Ferrando, Carlos, Aguilar, Gerardo, Muñoz, Tomás, Ferreres, José, Ambrós, Alfonso, Aldecoa, César, Suárez-Sipmann, Fernando, Thorpe, Kevin E., Jüni, Peter, Slutsky, Arthur S.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429135/
https://ncbi.nlm.nih.gov/pubmed/32799933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04643-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky